Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Kerstein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|May 20, 2022
Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarchingXiaoyang Yue, Junping Yin, Xiaoqing Wang, et al.
Frontiers in Immunology|April 25, 2018
Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated VasculitidesPeter Lamprecht, Anja Kerstein, Sebastian Klapa, et al.
Scientific Reports|September 28, 2020
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasisLucy Kappes, Ruba L Amer, Sabine Sommerlatte, et al.
Autoimmunity Reviews|November 27, 2022
Autoimmune pre-diseaseKatja Bieber, Jennifer E Hundt, Xinhua Yu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|May 20, 2022
Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarchingXiaoyang Yue, Junping Yin, Xiaoqing Wang, et al.
Frontiers in Immunology|April 25, 2018
Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated VasculitidesPeter Lamprecht, Anja Kerstein, Sebastian Klapa, et al.
Scientific Reports|September 28, 2020
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasisLucy Kappes, Ruba L Amer, Sabine Sommerlatte, et al.
Autoimmunity Reviews|November 27, 2022
Autoimmune pre-diseaseKatja Bieber, Jennifer E Hundt, Xinhua Yu, et al.
Pageof 2